These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [TBL] [Abstract][Full Text] [Related]
23. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182 [TBL] [Abstract][Full Text] [Related]
24. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis. Shatat IF; Schoeneman M; Flynn JT; Woroniecki RP Pediatr Nephrol; 2007 Jun; 22(6):834-9. PubMed ID: 17294224 [TBL] [Abstract][Full Text] [Related]
25. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. Gregory MJ; Smoyer WE; Sedman A; Kershaw DB; Valentini RP; Johnson K; Bunchman TE J Am Soc Nephrol; 1996 Apr; 7(4):543-9. PubMed ID: 8724887 [TBL] [Abstract][Full Text] [Related]
26. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798 [TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive agents for treating IgA nephropathy. Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292 [TBL] [Abstract][Full Text] [Related]
28. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543 [TBL] [Abstract][Full Text] [Related]
29. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340 [TBL] [Abstract][Full Text] [Related]
30. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis. Martinelli R; Pereira LJ; Silva OM; Okumura AS; Rocha H Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202 [TBL] [Abstract][Full Text] [Related]
31. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831 [TBL] [Abstract][Full Text] [Related]
32. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Segarra A; Vila J; Pou L; Majó J; Arbós A; Quiles T; Piera LL Nephrol Dial Transplant; 2002 Apr; 17(4):655-62. PubMed ID: 11917061 [TBL] [Abstract][Full Text] [Related]
33. [Cyclosporin A in the therapy of nephrotic syndrome caused by focal-segmental glomerulosclerosis]. Jovanović D; Kovacević Z; Rabrenović V Vojnosanit Pregl; 2000; 57(3):303-7. PubMed ID: 11039311 [TBL] [Abstract][Full Text] [Related]
34. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265 [TBL] [Abstract][Full Text] [Related]
37. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. Tune BM; Mendoza SA J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855 [TBL] [Abstract][Full Text] [Related]
38. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477 [TBL] [Abstract][Full Text] [Related]
39. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Burgess E Kidney Int Suppl; 1999 Jun; 70():S26-32. PubMed ID: 10369192 [TBL] [Abstract][Full Text] [Related]
40. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Gellermann J; Ehrich JH; Querfeld U Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]